"Chinese vaccines can save American lives." The situation of the COVID-19 epidemic escalated again. On the 26th, Bloomberg published an article by Tyler Cowen, a columnist and professor of economics at George Mason University, condemning the Trump government for launching a trade war against China. The article said that the biggest cost of the US China trade war is the lack of cooperation in combating COVID-19. China has made great progress in vaccine research and development. In principle, Americans can also benefit from it. However, the fact is that the United States has not invested in Chinese vaccines. At the time of this article's publication, the cumulative number of newly diagnosed cases in the United States has exceeded 8.6 million, and the cumulative number of deaths has exceeded 225000. The increasingly out of control epidemic is increasing the concern of the US media.
Bloomberg News: Chinese Vaccines Can Save American Lives
"Critics of President Trump's (launched) trade war with China stressed that the trade war has triggered rising consumer prices, huge aid to American farmers, and displeasure on both sides. At present, all the above views are correct, but not enough. The biggest cost of trade war is the lack of cooperation between the United States and China in vaccine and other biological progress, measured by the loss of life, continued commercial uncertainty and a longer economic recession. " The article begins by saying.
Next, the article specifically stated that, considering the position of the US side, it is impossible to know which new crown vaccine is the safest and most effective before further clinical trials and other studies, so the US federal government has pre purchased seven vaccines in advance. Through this measure, the United States can ensure that relevant enterprises are ready to accelerate the production of vaccines.
"At present, the investment portfolio is multinational companies (vaccines), including Pfizer, Sanofi, AstraZeneca and Johnson&Johnson. Ideally, (American investment) should include at least one Chinese vaccine," the topic of the article turned, and then said, "but not."
The article said that, obviously, considering the rhetoric of the current US government, it is difficult to use Chinese vaccines at the political level. "You cannot accuse Xinguan of being a 'Chinese virus' while telling Americans that they should be vaccinated with Chinese vaccines. Therefore, the Trump government has not made serious efforts to reach a vaccine sharing agreement with China," the article wrote.
"At first, some observers in the United States even laughed at China's efforts to develop vaccines." The article said, but so far, the situation has reversed - "China's (R&D) progress is faster than any other country, and it has many competitive vaccines, four of which are undergoing the third phase test." Although there is no final result, the article "named" that the relevant data shows that, The BBIBP CorV vaccine developed by the Chinese research team is likely to be safe. A recent paper published by the famous medical journal The Lancet also pointed out that the results are "very promising" and safe enough.
"With its extensive information gathering capability, China is conducting the third phase experiment openly and effectively at a faster speed. Whether you agree with this policy or not, in principle, Americans can benefit from it, because China has taken all the risks and provided relevant information."
The article goes on to say that another advantage of Chinese vaccines is that they can be used for rapid production and have high scalability. "From the perspective of pure biomedicine, Chinese vaccines may not be the most effective product, but they may be helpful (products)." China actively presales vaccines overseas and shares vaccine information, while "the United States still has not joined".
In the last part, the article goes straight to the theme, saying that if the United States really needs a Chinese vaccine, it may be an embarrassing publicity failure. "However, considering the huge damage caused by the new crown, the price paid for obtaining an effective vaccine is negligible."
"China has become an important participant in the biomedical field at a faster rate than most people think. Trade with China does not only involve iPhones, soybeans and Wal Mart plastic toys. Now, this is also a matter of life and death. When the trade war began, few Americans may know this. But one of the benefits of trade is that it creates precious opportunities that are difficult to foresee. " At the end of the article.
(Source: Global Network)